Renal Tumors Classification Biology and Banking Study
S
Sandeep Batra, MD
Primary Investigator
K
Kamnesh Pradhan, MD
Primary Investigator
Enrolling By Invitation
29 years and younger
All
Phase
N/A
10 participants needed
3 Locations
Overview
What is the purpose of this study?
This research trial studies kidney tumors in younger patients. The purpose of this study is to classify patients with renal tumors by
histological categorization, surgico-pathological stage, presence of
metastases, age at diagnosis, tumor weight, and loss of heterozygosity
for chromosomes 1p and 16q, to define eligibility for a series of
therapeutic studies; and to maintain a biological samples bank to make
specimens available to scientists to evaluate additional potential
biological prognostic variables and for the conduct of other research by
scientists.Collecting and storing samples of tumor tissue, blood, and urine from patients with cancer to study in the laboratory may help doctors learn more about changes that occur in deoxyribonucleic acid (DNA) and identify biomarkers related to cancer.
THIS STUDY IS ENROLLING BY INVITATION ONLY - Consistent with most oncology trials, patients are not actively “recruited,” but are screened by their physician for appropriate clinical trial(s) at the time of their routine clinic visit. Occasionally, a patient may be a self-referral or physician referral, but are still screened for appropriate clinical trials at the time of their routine clinic visit. PI and staff may send copies of relevant consent forms to these patients to look over prior to actually consenting or enrolling them. This may take place at the patient's visit at which the consent is presented or the patient's next visit to the outpatient hematology/oncology clinic.
Interested in participating? For more information about this research study or other cancer-related clinical trials at IU Simon Comprehensive Cancer Center, please contact:
IU Clinical Trials Office
Email: iutrials@iu.edu
Phone: (317) 278-5632
Description
What will happen during the study?
- Tumor tissue, blood, and urine samples are collected for research studies, including immunohistochemistry. CT scans and MRIs are also performed. Loss of heterozygosity analyses (chromosome 1p and 16q) are performed by extraction of DNA. DNA polymorphisms are assayed by polymerase chain reaction using standard methodology.
- Leftover specimens are archived for future studies. (LOH and INI1 testing discontinued as of April 2014)
- Patients are followed up periodically for 5 years.
Eligibility
You may be eligible for this study if you meet the following criteria:
-
Conditions:
Wilms Tumor, Riley
-
Age: - 29 Years
-
Gender: All
Updated on
12 Sep 2024.
Study ID: PHO-COG-FALLON-AREN03B2, 1010002644 (0605-02)
Please visit our main page to search for other studies you may be interested in.
If you need help finding a study or have any questions, please contact us at inhealth@iu.edu
